Germline Mutations in Pancreatic Adenocarcinoma

Plain-language summary

This observational study investigated germline (inherited) mutations in patients with pancreatic adenocarcinoma, a type of pancreatic cancer. Patients diagnosed with pancreatic adenocarcinoma at any stage were included. The study had no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Hellenic Cooperative Oncology Group

Intervention

Mutations

Start date

3/1/2016

Estimated completion

1/3/2020

Countries

Greece

Related genes

Locations

• Athens, Greece

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients diagnosed with adenocarcinoma of the pancreas
* All disease stages

Exclusion criteria

* Patients with pancreatic cancer, other than adenocarcinoma
* Non-eligible blood samples